According to Ironwood Pharmaceuticals 's latest financial reports the company's total liabilities are โฌ0.56 Billion. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | โฌ0.73 B | 76.98% |
2022-12-31 | โฌ0.41 B | -9.19% |
2021-12-31 | โฌ0.46 B | 13.95% |
2020-12-31 | โฌ0.40 B | -8.81% |
2019-12-31 | โฌ0.44 B | -4.14% |
2018-12-31 | โฌ0.46 B | -6.98% |
2017-12-31 | โฌ0.49 B | -18.78% |
2016-12-31 | โฌ0.61 B | 27.58% |
2015-12-31 | โฌ0.47 B | 142.08% |
2014-12-31 | โฌ0.19 B | 13.57% |
2013-12-31 | โฌ0.17 B | 168.58% |
2012-12-31 | โฌ64.9 M | -14.96% |
2011-12-31 | โฌ76.32 M | -28.41% |
2010-12-31 | โฌ0.10 B | -66.85% |
2009-12-31 | โฌ0.32 B | 21.92% |
2008-12-31 | โฌ0.26 B | 22.55% |
2007-12-31 | โฌ0.21 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
![]() Nektar Therapeutics
NKTR | โฌ0.20 B | -63.33% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | โฌ55.19 B | 9,748.08% | ๐ฌ๐ง UK |